Therapeutic Vaccines Market Scope And Analysis

Report Code : TIPRE00039849
Category : Life Sciences

Status : Published
No. of Pages : 207

Buy Now

Therapeutic Vaccines Market Analysis and Trends by 2031

Buy Now

Therapeutic Vaccines Market Report Scope

Report Attribute	Details
Market size in 2024	US$ 1,244.94 Million
Market Size by 2031	US$ 2,934.57 Million
Global CAGR (2024 - 2031)	13.0%
Historical Data	2021-2023
Forecast period	2024-2031
Segments Covered	By Product Cancer Vaccines Infectious Disease Vaccines By Technology Allogenic Vaccines Autologous Vaccines By End User Hospitals Clinics
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Dendreon BioNTech SE Serum Institute of India Pvt Ltd Merck Co Inc Amgen Inc ISA Pharmaceuticals BV INOVIO Pharmaceuticals Inc Transgene SA THERAVECTYS SA CureVac SE

Therapeutic Vaccines Market News and Recent Developments

The therapeutic vaccines market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the therapeutic vaccines market are listed below:

TheraVectys has announced the enrollment of the first patient in Phase I/IIa clinical trial assessing the oncotherapeutic vaccine Lenti-HPV-07 for the treatment of HPV-induced cancers. Lenti-HPV-07 vaccine is based on the lentiviral vector technology platform developed by the Pasteur-TheraVectys Joint Laboratory, and TheraVectys has pioneered it over the past two decades. (Source: TheraVectys, Press Release, October 2024)
Serum Institute of India, the world's largest vaccine manufacturer by dose volume, entered into an exclusive global agreement with ImmunityBio, Inc., to supply Bacillus Calmette-Guerin (BCG) to ImmunityBio. The deal includes the production of standard BCG, approved for use outside the US, and a next-generation recombinant BCG (iBCG), currently undergoing testing. The iBCG is intended for use in combination with ImmunityBio's ANKTIVA for both approved and potential future indications, subject to regulatory approval. The two companies will collaborate to expedite the Phase 2 clinical trials of iBCG being conducted in Europe. (Source: Serum Institute of India Pvt. Ltd, Press Release, May 2024)

Therapeutic Vaccines Market Report Coverage and Deliverables

The "Therapeutic Vaccines Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

Therapeutic vaccines market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Therapeutic vaccines market trends and market dynamics such as drivers, restraints, and key opportunities
Detailed PEST and SWOT analysis
Therapeutic vaccines market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the therapeutic vaccines market
Detailed company profiles